The U.S. Food and Drug Administration has approved Janssen Biotech's Sylvant , an orphan drug for patients with multicentric Castleman's disease .
http://ift.tt/1hdbLcu?
http://ift.tt/1hdbLcu?
Healthcare Law News: News on Healthcare Law continually updated from thousands of sources monitored by the B Media Network.
No comments:
Post a Comment